BACKGROUND: We describe the development and clinical validation of a patient self-administered tool assessing the quality of multiple sclerosis diagnosis disclosure. METHOD: A multiple sclerosis expert panel generated questionnaire items from the Doctor's Interpersonal Skills Questionnaire, literature review, and interviews with neurology inpatients. The resulting 19-item Comunicazione medico-paziente nella Sclerosi Multipla (COSM) was pilot tested/debriefed on seven patients with multiple sclerosis and administered to 80 patients newly diagnosed with multiple sclerosis. The resulting revised 20-item version (COSM-R) was debriefed on five patients with multiple sclerosis, field tested/debriefed on multiple sclerosis patients, and field tested on 105 patients newly diagnosed with multiple sclerosis participating in a clinical trial on an information aid. The hypothesized monofactorial structure of COSM-R section 2 was tested on the latter two groups. RESULTS: The questionnaire was well accepted. Scaling assumptions were satisfactory in terms of score distributions, item-total correlations and internal consistency. Factor analysis confirmed section 2's monofactorial structure, which was also test-retest reliable (intraclass correlation coefficient [ICC] 0.73; 95% CI 0.54-0.85). Section 1 had only fair test-retest reliability (ICC 0.45; 95% CI 0.12-0.69), and three items had 8-21% missed responses. CONCLUSIONS: COSM-R is a brief, easy-to-interpret MS-specific questionnaire for use as a health care indicator.
BACKGROUND: We describe the development and clinical validation of a patient self-administered tool assessing the quality of multiple sclerosis diagnosis disclosure. METHOD: A multiple sclerosis expert panel generated questionnaire items from the Doctor's Interpersonal Skills Questionnaire, literature review, and interviews with neurology inpatients. The resulting 19-item Comunicazione medico-paziente nella Sclerosi Multipla (COSM) was pilot tested/debriefed on seven patients with multiple sclerosis and administered to 80 patients newly diagnosed with multiple sclerosis. The resulting revised 20-item version (COSM-R) was debriefed on five patients with multiple sclerosis, field tested/debriefed on multiple sclerosispatients, and field tested on 105 patients newly diagnosed with multiple sclerosis participating in a clinical trial on an information aid. The hypothesized monofactorial structure of COSM-R section 2 was tested on the latter two groups. RESULTS: The questionnaire was well accepted. Scaling assumptions were satisfactory in terms of score distributions, item-total correlations and internal consistency. Factor analysis confirmed section 2's monofactorial structure, which was also test-retest reliable (intraclass correlation coefficient [ICC] 0.73; 95% CI 0.54-0.85). Section 1 had only fair test-retest reliability (ICC 0.45; 95% CI 0.12-0.69), and three items had 8-21% missed responses. CONCLUSIONS: COSM-R is a brief, easy-to-interpret MS-specific questionnaire for use as a health care indicator.
Authors: Alessandra Solari; Ambra Mara Giovannetti; Andrea Giordano; Carla Tortorella; Valentina Torri Clerici; Giampaolo Brichetto; Franco Granella; Alessandra Lugaresi; Francesco Patti; Marco Salvetti; Ilaria Pesci; Eugenio Pucci; Diego Centonze; Maura Chiara Danni; Simona Bonavita; Diana Ferraro; Antonio Gallo; Alberto Gajofatto; Viviana Nociti; Luigi Grimaldi; Monica Grobberio; Roberta Lanzillo; Rachele Di Giovanni; Silvia Gregori; Alessia Manni; Erika Pietrolongo; Sarah Bertagnoli; Marco Ronzoni; Laura Compagnucci; Roberta Fantozzi; Beatrice Allegri; Sebastiano Arena; Maria Chiara Buscarinu; Loredana Sabattini; Maria Esmeralda Quartuccio; Elena Tsantes; Paolo Confaloneri; Andrea Tacchino; Insa Schiffmann; Anne Christin Rahn; Ingo Kleiter; Michele Messmer Uccelli; Anna Barabasch; Christoph Heesen Journal: Front Neurol Date: 2019-08-22 Impact factor: 4.003